- Home
- SLN vs FLWS Comparison
SLN vs FLWS Comparison
Compare SLN & FLWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLN
- FLWS
- Stock Information
- Founded
- SLN 1994
- FLWS 1976
- Country
- SLN United Kingdom
- FLWS United States
- Employees
- SLN N/A
- FLWS N/A
- Industry
- SLN Biotechnology: Pharmaceutical Preparations
- FLWS Other Specialty Stores
- Sector
- SLN Health Care
- FLWS Consumer Discretionary
- Exchange
- SLN Nasdaq
- FLWS Nasdaq
- Market Cap
- SLN 268.8M
- FLWS 268.5M
- IPO Year
- SLN N/A
- FLWS 1999
- Fundamental
- Price
- SLN $6.59
- FLWS $4.39
- Analyst Decision
- SLN Buy
- FLWS Hold
- Analyst Count
- SLN 6
- FLWS 1
- Target Price
- SLN $39.67
- FLWS $7.50
- AVG Volume (30 Days)
- SLN 115.5K
- FLWS 505.3K
- Earning Date
- SLN 11-13-2025
- FLWS 10-30-2025
- Dividend Yield
- SLN N/A
- FLWS N/A
- EPS Growth
- SLN N/A
- FLWS N/A
- EPS
- SLN N/A
- FLWS N/A
- Revenue
- SLN $27,169,000.00
- FLWS $1,685,658,000.00
- Revenue This Year
- SLN N/A
- FLWS N/A
- Revenue Next Year
- SLN N/A
- FLWS $0.99
- P/E Ratio
- SLN N/A
- FLWS N/A
- Revenue Growth
- SLN 22.28
- FLWS N/A
- 52 Week Low
- SLN $1.97
- FLWS $3.86
- 52 Week High
- SLN $19.36
- FLWS $9.24
- Technical
- Relative Strength Index (RSI)
- SLN 69.56
- FLWS 37.28
- Support Level
- SLN $5.00
- FLWS $4.18
- Resistance Level
- SLN $5.83
- FLWS $4.63
- Average True Range (ATR)
- SLN 0.41
- FLWS 0.20
- MACD
- SLN 0.16
- FLWS -0.00
- Stochastic Oscillator
- SLN 93.42
- FLWS 30.43
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
About FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.